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Abstract Malondialdehyde (MDA) is an end-product of
lipid peroxidation and a side product of thromboxane A2
synthesis. Moreover, it is not only a frequently measured
biomarker of oxidative stress, but its high reactivity and
toxicity underline the fact that this molecule is more than
‘‘just’’ a biomarker. Additionally, MDA was proven to be a
mutagenic substance. Having said this, it is evident that
there is a major interest in the highly selective and sensitive
analysis of this molecule in various matrices. In this
review, we will provide a brief overview of the most recent
developments and techniques for the liquid chromatogra-
phy (LC) and gas chromatography (GC)-based analysis of
MDA in different matrices. While the 2-thiobarbituric acid
assay still is the most prominent methodology for deter-
mining MDA, several advanced techniques have evolved,
including GC–MS(MS), LC–MS(MS) as well as several
derivatization-based strategies.
Keywords Malondialdehyde (MDA)  Derivatization 
LC–MS(MS)  Biomarker
Introduction
Malondialdehyde (MDA) is an end-product of the radical-
initiated oxidative decomposition of poly-unsaturated fatty
acids and, therefore, it is a frequently measured biomarker
of oxidative stress [1]. More information about reactive
carbonyls and proposed intermediates can be found in [2].
In addition, MDA is generated as a side product of
thromboxane A2 synthesis [3] and by gamma irradiation of
DNA [4]. In case of thromboxane A2 synthesis, MDA is
formed during the conversion of the endoperoxide prosta-
glandin H2 (PGH2) by thromboxane synthase [5]. PGH2 is
derived from arachidonic acid by conversion via cycloox-
ygenases [6].
Particularly, MDA’s high reactivity and capability of
forming adducts with multiple biological molecules such as
proteins or DNA has attracted major attention over the last
decades [7, 8]. MDA’s high reactivity is mainly based on its
electrophilicity making it strongly reactive toward nucleo-
philes, such as basic amino acid residues (i.e., lysine and
histidine). This reactivity is not only based on MDA’s
aldehydicnaturebutisalsoinﬂuencedbyits1,3-dialdehydic
structure making it possible to form mesomerically stabi-
lizedSchiffbases.Aswillbediscussedbelow,especiallythis
high reactivity towards nucleophilic molecules has been
extensivelyexploitedduringthelastyearstodevelopseveral
derivatization strategies for MDA. Furthermore, MDA’s
high reactivity has for example also been used for the con-
trolled modiﬁcation of basic amino acids in proteomics
studies[9].Asexamplesthestructureofameta-stablelysine
and a stable arginine adduct with MDA is shown in Fig. 1.
However, not only in the life sciences ﬁeld but also in
food analysis, MDA serves as a biomarker of lipid oxida-
tion (oxidative decomposition) [12, 13]. MDA’s potential
mutagenicity, atherogenicity and cancerogenicity [14]
additionally underline the importance of monitoring this
substance.
Taken together, these facts point out that MDA is not
simply a biomarker for the oxidative decomposition of
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derived from other sources and more importantly shows
physiological relevance as it is capable of forming DNA
and protein adducts [8, 15].
Several different strategies have been pursued for
measuring MDA in a variety of different matrices (i.e.,
plasma, urine, and saliva). The employed analytical strat-
egies can roughly be sub-divided into derivatization-based
and label-free methodologies. Particularly for the analysis
of biological matrices, these strategies have been coupled
to separation techniques such as liquid chromatography
(LC) or gas chromatography (GC). Due to its high reac-
tivity, the majority of present MDA might be bound to
plasma proteins and other species. Hence, it is important to
emphasize whether the free or total MDA level is deter-
mined. Referring to this fact, it is also essential to choose
suitable sample preparation conditions particularly hydro-
lysis conditions when total MDA is to be analyzed and to
consider the release and/or formation of MDA when harsh
derivatization conditions are to be applied [16]. An over-
view about selected analysis techniques for MDA is given
in Table 1.
Analysis of Malondialdehyde
Label-Free Analysis
Several possibilities for the label-free analysis of MDA
exist, ranging from simple UV-based methodologies to
LC–MS(MS) platforms.
Malondialdehyde has a pKa value of approximately 4.5
and a melting point of around 72 C[ 17]. The rather low
pKa value of MDA can be explained from its mesomeric
structure (Fig. 2). Basically, MDA can be drawn either as a
di-aldehyde or as a vinylogenic carboxylic acid to explain
the low pKa value observed for this substance. Based on its
mesomeric structure, which possesses a a,b-unsaturated
carbonyl function, MDA can spectrophotometrically be
determined under acidic conditions at 245 nm or under
alkaline conditions at 267 nm [18, 19].
It is evident that such an ultraviolet (UV) absorbance-
based methodology carried out at low wavelengths suffers
from rather poor sensitivity and selectivity, especially
when biological matrices are involved. Hence, separation
techniques such as reversed-phase liquid chromatography
(LC) [20] or capillary electrophoresis (CE) [21] have been
used to separate MDA from matrix constituents and to
facilitate its detection by UV-absorbance. While Karatas
et al. [20] used perchloric acid (HClO4) for protein pre-
cipitation and the release of bound MDA in human serum
samples, Wilson et al. [21] applied a combined centrifu-
gation, ﬁltration approach to prepare plasma samples for
analysis.
An LC–MS(MS)-based methodology employing a tri-
ple-quadrupole mass spectrometer (MS) and a porous
graphite column (Hypercarb) for the measurement of MDA
and other biomarkers of oxidative stress in exhaled breath
condensate, urine and plasma was recently published by
Syslova ´ et al. [22]. The method showed very low limits of
detection (LOD) for all mentioned matrices and can be
applied without the necessity of labeling MDA. Although
the method of Syslova ´ et al. did not demand any deriva-
tization allowing the detection of MDA, solid-phase
extraction (SPE), incorporating methylmalondialdehyde as
internal standard, was applied to exhaled breath condensate
(EHB) and urine samples, while plasma samples underwent
protein precipitation as sample pretreatment. Limits of
Fig. 1 MDA adducts of
a lysine–N
e-b-lysyl-
aminoacrolein and b arginine–
N
d-(2-pyrimidyl)-L-ornithine
[10, 11] as MDA adduct
formation mainly occurs on
the protein level as shown in the
a-amino carboxylic acid group
would be incorporated into a
peptide bond
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123detection (LOD) as low as 32 pg/mL (0.4 nM) in exhaled
breath condensate could be reached. A representative
chromatogram of a urine sample is shown in Fig. 3.
Derivatization-Based Methodologies
The vast majority of analytical approaches for the deter-
mination of MDA make use of some kind of derivatization.
Most strategies are based on the ‘‘aldehydic-reactivity’’ of
MDA, hence employing hydrazine-based derivatization
reagents.
Still, the most frequently applied technology is the
‘‘classic’’ 2-thiobarbituric acid (TBA) assay [23] in which
two molecules of TBA condense with one molecule of
MDA to give a colored reaction product (cf Fig. 4), which
can be measured spectrophotometrically at 535 nm, or by
ﬂuorescence detection with excitation at 530 nm and
emission at 550 nm. The TBA assay intrinsically is not
speciﬁc for MDA [24], and therefore, it is frequently
combined with LC separation and ﬂuorescence detection of
the formed products [25]. Still, the TBA assay including
the LC step was reported to overestimate urinary MDA
concentrations by almost tenfold. This might be related to
the harsh conditions (100 C, acidic conditions) needed to
yield the colored reaction product. In a recent study,
examining the inter-laboratory variation in the measure-
ment of oxidative stress biomarkers, which was mainly
accomplished by the combined LC-TBA assay, Breusing
et al. [26] could show huge variations between the actual
measured MDA levels in irradiated human plasma samples.
Surprisingly, in this study the LC-TBA assay proved to
give the lowest MDA levels when compared to other assay
formats.
LC–UV/FD Analysis
Due to the drawbacks of the classic TBA assay being non-
speciﬁc for MDA and not allowing a distinction between
free and bound MDA, several novel approaches for the
speciﬁc determination of MDA have been developed.
Especially hydrazine-based derivatization reagents, such as
dinitrophenylhydrazine (DNPH) [27], FMOC-hydrazine
[28], or dansylhydrazine [29], have been employed in the
LC analysis of MDA. While DNPH has been used in
combination with UV detection, the later reagents were
used for the ﬂuorescence detection of the resulting deriv-
atives. All of these reagents have been used to determine
MDA in human plasma, DNPH has additionally been
applied to determine MDA in human urine [23]. Dans-
ylhydrazine in combination with a so-called solid-phase
analytical derivatization (SPAD) where the derivatization
is carried out on a solid support has also been applied for
the analysis of MDA in mouse tissue homogenates [30].
Sample preparation in the cited DNPH-based method
[27], included alkaline hydrolysis for MDA release, fol-
lowed by a HClO4-based protein precipitation and deriva-
tization. Finally, the derivatives had to be extracted with
hexane, dried and reconstituted before analysis. Another
study involving the DNPH reagent to investigate urinary
MDA levels [23], described a combined derivatization
extraction step, involving pentane as the extraction solvent.
Especially for the preparation of the derivatization reagent
solution, the authors describe a rather elaborate protocol,
including chloroform extractions subsequent to preparing
the reagent solution in 4 N HCl. In case of the FMOC
reagent [28], free MDA could be analyzed by protein
precipitation with subsequent derivatization prior to anal-
ysis. A more automated extraction and derivatization pro-
tocol is presented in the SPAD-based analysis platforms
[29, 30], which have been used to determine MDA in tissue
homogenates as well as plasma samples. Although the
SPAD analysis is a fully automated process, its complexity
might be a complication for its applicability to large
sample cohorts.
Three non-hydrazine-based reagents which were used
for the determination of MDA are: 1-methyl-2-phenylin-
dole [31], which is a colorimetric reagent, forming a
chromophore with a UV absorbance maximum at 586 nm.
Diaminonaphthalene [32], which was used for the LC-UV
based determination of free and bound MDA in human
plasma samples, and 2-aminoacridone (2-AA) [33], which
was used for the LC–ﬂuorescence detection (FD) of free
MDA in human urine.
Fig. 2 Mesomeric structures of MDA
Fig. 3 Chromatogram of a urine sample obtained with the label-free
LC–MS/MS method, described by Syslova ´ et al. [22] (taken with
permission from [22]). MDA malondialdehyde, MeMDA methylmal-
ondialdehyde, HNE hydroxynonenal, 8-iso PGF2a 8-iso prostaglandin
F2a
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123In the case of methyl-2-phenylindole, the reagent is
directly added to the sample of interest (i.e., plasma and
tissues homogenate), the mixture is incubated and centri-
fuged before the absorbance is read. In the case of diami-
nonaphthalene, protein precipitation with or without
release of MDA from proteins was applied. The authors
described the limit of detection for their method to be
better than 50 pM being very low for a UV-based meth-
odology [32]. Urine samples derivatized with 2-AA did not
undergo any sample pretreatment. In case of the 2-AA
reaction, the formed derivative showed distinct changes in
the conjugated p-system, and, respectively, in its UV-
absorbance as well as ﬂuorescence properties, thereby
possibly allowing the development of a speciﬁc plate
reader-based assay (see Fig. 4). Other advantages of this
methodology are: (a) the simple derivatization protocol,
which basically consists of mixing the urine sample with
citrate buffer and reagent solution followed by an incuba-
tion step (90 min) and (b) the possibility of isocratic
analysis, thereby allowing a rather high throughput as
sample analysis times in this case were described to be less
than 4 min [33].
LC–MS(MS) Analysis
Besides the fact that most MDA derivatives are analyzed
by LC–UV or LC–FD analysis, also LC–MS(MS)-based
strategies involving a derivatization procedure have been
described. One such approach uses DNPH and deuterium-
labeled d3-DNPH to apply a novel isotope dilution tech-
nique called alternate isotope-coded derivatization
assay (AIDA) for the determination of MDA and other
biomarkers of oxidative stress in exhaled breath conden-
sate [34]. Another reagent used for the LC–MS detection
of MDA and other aldehydes is 4-(2-(trimethylammo-
nio)ethoxy)benzenaminium halide (4-APC), which is cou-
pled via reductive amination to the aldehyde group [35].
This reagent was used in combination with an on-line
weak cation exchange (WCX) solid-phase extraction
LC–MS system, for the detection of MDA and other
aldehydes in urine and plasma [36]. In case of urine
samples, a simple centrifugation step was carried out as
sample pretreatment, while plasma samples underwent
protein precipitation with acetonitrile before being sub-
jected to derivatization and subsequent analysis by on-line
SPE LC–MS [36].
Gas Chromatographic MDA Analysis
As for the LC-based determinations, hydrazine labels dom-
inate the employed strategies for the GC-based methodolo-
giesaswell.PhenylhydrazinehasbeenusedtoanalyzeMDA
in plasma and microsomal samples [16], as due to very mild
reaction conditions free as well as total MDA levels can be
determined. Pentaﬂuorophenylhydrazine has been used for
the head space-based analysis of MDA in urine [37]. A
combined head space–solid phase micro extraction (SPME)
approach for the determination of MDA in human blood
incorporated triﬂuoroethylhydrazine as derivatization
reagent [38] (see Fig. 4). Along these lines also meth-
ylhydrazine has to be named, which was used for the
GC–nitrogen phosphorusdetector(NPD)-based detectionof
MDA in various matrices [2, 39]. Another hydrazine-based
label which was used in combination with an electron cap-
ture detector (ECD) is 2,4,6-trichlorophenylhydrazine
(TCPH) [40]. The reagent was developed for the determi-
nation of total MDA in urine samples [41].
Two non-hydrazine-based reagents which have been used
for the analysis of MDA by GC–MS(MS) are penta-
ﬂuorophenylbromide [42]a n dO-(2,3,4,5,6-pentaﬂuorbenzyl)
Fig. 4 Reaction of MDA with different derivatization reagents, a TBA assay, b labeling with 2,2,2-triﬂuoroethylhydrazine, c labeling with 2-AA
(reprinted with permission from [33, 45]
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123hydroxylamine hydrochloride [43]. Pentaﬂuorophenylbro-
mide yields a doubly derivatized species, which was analyzed
via GC–MS(MS) analysis in the selected reaction monitoring
mode (m/z 253 ? 177 and m/z 251 ? 175). The second
reagent, O-(2,3,4,5,6-pentaﬂuorbenzyl)hydroxylamine was
used to determine MDA in rat urine by a GC–ECD based
method [43].
In the case of plasma samples, Cighetti et al. [16]
applied a liquid–liquid extraction (LLE) employing hexane
after derivatization, with or without previous protein pre-
cipitation using acetonitrile (ACN). In case of microsomal
incubations, an additional ﬁltration step was applied. Shin
et al. as well as Fujioka and Shibamoto could successfully
circumvent the need of protein precipitation or LLE in
urine, blood and cod liver oil samples by employing head
space or head space SPME analysis after MDA derivati-
zation [37–39]. When the TCPH reagent was applied to
defatted plasma samples, the sample preparation involved
LLE and a drying step over anhydrous sodium sulfate
before subsequent drying under nitrogen was carried out
[40]. Dreissigacker et al. [42] employed a toluene extrac-
tion of the dried residue after derivatizing whole plasma
samples. De Zwart et al. [43] analyzed total MDA after
acid hydrolysis in rat urine samples. After derivatization,
LLE employing heptane and a drying step over sodium
sulfate were applied.
Conclusions
Malondialdehyde has been analyzed in a wide variety of
different matrices in numerous studies dealing with oxi-
dative stress parameters or the modiﬁcation of endogenous
substances such as proteins, or DNA. Several technologies
for the determination of free and total MDA which are
more sensitive and selective compared to the classic TBA
assay have been developed during the last decade.
Although the superior performance of all these methods
has been proven, the TBA assay is still widely applied,
even though its unspeciﬁc nature is known today. The most
likely reason for this might be its convenient utilization in
particular to large sample numbers, needing only a plate
reader instrument. Hence, it seems to be crucial to develop
a selective and sensitive derivatization strategy for MDA,
which can easily be applied to large sample cohorts. Such a
reagent could possibly evolve from a non-hydrazine-based
reagent, such as 2-aminoacridone, where the coupling of
MDA causes distinct changes in the spectroscopic prop-
erties and thereby might lead to a selective plate reader-
based detection of this important substance. Another
strategy to develop such a plate reader-based analysis
platform might be the development of Fo ¨rster resonance
energy transfer (FRET)-based derivatization strategies [44]
for MDA. Such reagents could possibly be developed on
the basis of the aromatic amine binding properties of MDA
(cf 2-AA), changing the spectroscopic properties of a pri-
mary ﬂuorescent molecule, now allowing FRET, involving
a secondary ﬂuorescent part of the reagent. Additional
possibilities for the development of advanced detection
technologies for MDA might also arise from so-called
f-trap reagents, which due to their ﬂuorine containing
nature allow the selective removal of excess reagent via
ﬂuorous solid phases [44].
The method of Syslova ´ et al. [22] offers a highly sen-
sitive analysis method for MDA, which does not require a
derivatization step. The main drawback of the method is
the need for highly expensive equipment, such as the
employed triple-quadrupole MS. Within the derivatization-
based methods, the GC-(head space) SPME methodologies
and the 2-AA based method for urine samples seem to be
superior as they demand minimal sample pretreatment and
show low limits of detection.
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